معرفی
Dr. Ellie Watson is a medical researcher with expertise in post-acute COVID-19 conditions, respiratory medicine, and clinical decision support systems. She is actively involved in major UK research initiatives including the PHOSP-COVID Study Collaborative Group and ISARIC4C Investigators, contributing to our understanding of long-term effects following SARS-CoV-2 infection.
Her research interests span several critical areas of clinical medicine:
- Long-term respiratory consequences of COVID-19
- Immune system changes following viral infection
- Development and validation of clinical decision tools
- Obstetric diagnostics and triage protocols
- Diagnostic approaches for neurodevelopmental conditions
Dr. Watson's work has been published in high-impact medical journals including multiple Lancet publications and Immunity and Ageing. Her research has accumulated 163 citations, with her 2018 paper on facial expression recognition in autism being particularly influential (95 citations).
She completed her doctoral thesis in 2021 on the evaluation of the QUiPP app for triage and transfer in preterm labor cases, demonstrating her expertise in both clinical research methodology and obstetric care. Her recent work (2023-2024) has significantly advanced our understanding of post-COVID dyspnea and immune aging.
Dr. Watson's research directly informs clinical practice guidelines and contributes to improved patient outcomes across multiple medical specialties, particularly in the management of post-acute conditions following hospitalization.
